These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 27084777

  • 1. Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer.
    Fu AZ, Tsai HT, Haque R, Ulcickas Yood M, Van Den Eeden SK, Cassidy-Bushrow AE, Zhou Y, Keating NL, Smith MR, Aaronson DS, Potosky AL.
    World J Urol; 2016 Dec; 34(12):1611-1619. PubMed ID: 27084777
    [Abstract] [Full Text] [Related]

  • 2. Impact of Early Salvage Androgen Deprivation Therapy in Localized Prostate Cancer after Radical Prostatectomy: A Propensity Score Matched Analysis.
    Park JW, Jang WS, Koh DH, Ham WS, Rha KH, Hong SJ, Choi YD.
    Yonsei Med J; 2018 Jul; 59(5):580-587. PubMed ID: 29869455
    [Abstract] [Full Text] [Related]

  • 3. Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer.
    Fu AZ, Tsai HT, Haque R, Yood MU, Cassidy-Bushrow AE, Van Den Eeden SK, Keating NL, Smith MR, Zhou Y, Aaronson DS, Potosky AL.
    J Urol; 2017 Jun; 197(6):1448-1454. PubMed ID: 28007467
    [Abstract] [Full Text] [Related]

  • 4. Less advanced disease at initiation of salvage androgen deprivation therapy is associated with decreased mortality following biochemical failure post-salvage radiation therapy.
    Foster CC, Jackson WC, Foster BC, Johnson SB, Feng FY, Hamstra DA.
    Radiat Oncol; 2014 Nov 26; 9():245. PubMed ID: 25424123
    [Abstract] [Full Text] [Related]

  • 5. Treatment failure and clinical progression after salvage therapy in men with biochemical recurrence after radical prostatectomy: radiotherapy vs androgen deprivation.
    Song C, Kim YS, Hong JH, Kim CS, Ahn H.
    BJU Int; 2010 Jul 26; 106(2):188-93. PubMed ID: 20002666
    [Abstract] [Full Text] [Related]

  • 6. Survival outcomes in men receiving androgen-deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year single-centre experience.
    DiBlasio CJ, Malcolm JB, Hammett J, Wan JY, Aleman MA, Patterson AL, Wake RW, Derweesh IH.
    BJU Int; 2009 Nov 26; 104(9):1208-14. PubMed ID: 19388987
    [Abstract] [Full Text] [Related]

  • 7. Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA.
    Jang JW, Hwang WT, Guzzo TJ, Wein AJ, Haas NB, Both S, Vapiwala N.
    Int J Radiat Oncol Biol Phys; 2012 Aug 01; 83(5):1493-9. PubMed ID: 22401922
    [Abstract] [Full Text] [Related]

  • 8. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR, CaPSURE Investigators.
    Cancer; 2006 Apr 15; 106(8):1708-14. PubMed ID: 16544313
    [Abstract] [Full Text] [Related]

  • 9. Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.
    Obata H, Shiota M, Akitake N, Takeuchi A, Kashiwagi E, Dejima T, Kiyoshima K, Inokuchi J, Tatsugami K, Eto M.
    Anticancer Res; 2017 Oct 15; 37(10):5631-5637. PubMed ID: 28982880
    [Abstract] [Full Text] [Related]

  • 10. Salvage radiation therapy following radical prostatectomy. A national Danish study.
    Ervandian M, Høyer M, Petersen SE, Sengeløv L, Hansen S, Holmberg M, Sveistrup J, Meidahl Petersen P, Borre M.
    Acta Oncol; 2016 May 15; 55(5):598-603. PubMed ID: 26399602
    [Abstract] [Full Text] [Related]

  • 11. Tailored treatment including radical prostatectomy and radiation therapy + androgen deprivation therapy versus exclusive radical prostatectomy in high-risk prostate cancer patients: results from a prospective study.
    Castelli T, Russo GI, Favilla V, Urzi D, Spitaleri F, Reale G, Giardina R, Saita A, Madonia M, Cimino S, Morgia G.
    Int Braz J Urol; 2014 May 15; 40(3):322-9. PubMed ID: 25010298
    [Abstract] [Full Text] [Related]

  • 12. Long-term Impact of Androgen-deprivation Therapy on Cardiovascular Morbidity After Radiotherapy for Clinically Localized Prostate Cancer.
    Kohutek ZA, Weg ES, Pei X, Shi W, Zhang Z, Kollmeier MA, Zelefsky MJ.
    Urology; 2016 Jan 15; 87():146-52. PubMed ID: 26476405
    [Abstract] [Full Text] [Related]

  • 13. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
    Tsai HK, D'Amico AV, Sadetsky N, Chen MH, Carroll PR.
    J Natl Cancer Inst; 2007 Oct 17; 99(20):1516-24. PubMed ID: 17925537
    [Abstract] [Full Text] [Related]

  • 14. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
    Kupelian PA, Buchsbaum JC, Elshaikh M, Reddy CA, Zippe C, Klein EA.
    Cancer; 2002 Dec 01; 95(11):2302-7. PubMed ID: 12436435
    [Abstract] [Full Text] [Related]

  • 15. Early Versus Delayed Initiation of Salvage Androgen Deprivation Therapy and Risk of Prostate Cancer-Specific Mortality.
    Mahal BA, Chen MH, Renshaw AA, Loffredo MJ, Kantoff PW, D'Amico AV.
    J Natl Compr Canc Netw; 2018 Jun 01; 16(6):727-734. PubMed ID: 29891524
    [Abstract] [Full Text] [Related]

  • 16. Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy.
    Yang DD, Muralidhar V, Mahal BA, Nezolosky MD, Labe SA, Vastola ME, Boldbaatar N, King MT, Martin NE, Orio PF, Choueiri TK, Trinh QD, Den RB, Spratt DE, Hoffman KE, Feng FY, Nguyen PL.
    Urol Oncol; 2017 Sep 01; 35(9):542.e25-542.e32. PubMed ID: 28533151
    [Abstract] [Full Text] [Related]

  • 17. Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer.
    Katz MS, Zelefsky MJ, Venkatraman ES, Fuks Z, Hummer A, Leibel SA.
    J Clin Oncol; 2003 Feb 01; 21(3):483-9. PubMed ID: 12560439
    [Abstract] [Full Text] [Related]

  • 18. Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study.
    Kim M, Song C, Jeong IG, Choi SK, Park M, Shim M, Kim YS, You D, Hong JH, Kim CS, Ahn H.
    BMC Cancer; 2018 Mar 09; 18(1):271. PubMed ID: 29523103
    [Abstract] [Full Text] [Related]

  • 19. Management Options for Biochemically Recurrent Prostate Cancer.
    Fakhrejahani F, Madan RA, Dahut WL.
    Curr Treat Options Oncol; 2017 May 09; 18(5):26. PubMed ID: 28434181
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular and Skeletal-related Events Following Localized Prostate Cancer Treatment: Role of Surgery, Radiotherapy, and Androgen Deprivation.
    Wallis CJ, Mahar AL, Satkunasivam R, Herschorn S, Kodama RT, Lee Y, Kulkarni GS, Narod SA, Nam RK.
    Urology; 2016 Nov 09; 97():145-152. PubMed ID: 27502032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.